The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV), which attacks the liver and can lead to symptoms such as jaundice, nausea, abdominal pain, and liver failure in severe cases ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2024 results of operations. “Gilead’s third quarter results are the strongest o ...